Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06084676 · ClinicalTrials.gov registry record
Organoid Model Predictive of Response to Immunotherapies
A clinical trial, sponsored by Indiana University.
- Terminated
- Registry status
- 1
- Enrollment target
NCT06084676 is a clinical trial that was terminated before completion, run by Indiana University. The registered enrollment target is 1 participants.
The verdict
NCT06084676 was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to create models out of tissue samples and treat those models with the same immunotherapy treatment the patient will be receiving, in order to validate this process and to predict responses to therapies and use it to choose the best treatments for people in the future. The researchers will then examine the direct effects of the treatment on those models.
Interventions
- DRUG Immunotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2024-01-22 |
| Est. Completion | 2024-02-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06084676
The ClinicalTrials.gov registry entry for NCT06084676 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Immunotherapy is the first listed.
NCT06084676 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06084676 about?
NCT06084676 is a clinical study titled "Organoid Model Predictive of Response to Immunotherapies". The purpose of this study is to create models out of tissue samples and treat those models with the same immunotherapy treatment the patient will be receiving, in order to validate this process and to predict responses to therapies and use it to choose the best treatments for people in the future. T...
What is the current status of trial NCT06084676?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2024-01-22. Estimated completion is 2024-02-26.
What interventions are being tested in trial NCT06084676?
The interventions under investigation include: Immunotherapy (DRUG).
Who is sponsoring clinical trial NCT06084676?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.